tiprankstipranks
Trending News
More News >
Wuestenrot & Wuerttembergische (DE:WUW)
:WUW

Wuestenrot & Wuerttembergische (WUW) AI Stock Analysis

Compare
5 Followers

Top Page

DE

Wuestenrot & Wuerttembergische

(LSE:WUW)

Rating:64Neutral
Price Target:
Wuestenrot & Wuerttembergische's overall score reflects moderate financial stability with challenges in profitability and operational efficiency. The stock shows positive technical momentum, yet the valuation appears high with a P/E ratio suggesting overvaluation concerns. The strong dividend yield partially offsets valuation apprehensions. Cash flow improvements provide a positive outlook, though previous volatility remains a risk factor.

Wuestenrot & Wuerttembergische (WUW) vs. iShares MSCI Germany ETF (EWG)

Wuestenrot & Wuerttembergische Business Overview & Revenue Model

Company DescriptionWuestenrot & Wuerttembergische (WUW) is a prominent German financial services group specializing in both banking and insurance sectors. The company offers a wide range of products, including life and health insurance, property and casualty insurance, and various savings and investment products. With a focus on providing comprehensive financial solutions, WUW caters to both individual and corporate clients, ensuring a broad market presence in the financial services industry.
How the Company Makes MoneyWuestenrot & Wuerttembergische generates revenue through its diverse portfolio of financial products and services. The company earns income from insurance premiums across its life, health, and property and casualty insurance offerings. Additionally, WUW benefits from investment income generated through its asset management activities. In the banking sector, the company earns money through interest income on loans and mortgages, as well as fees associated with savings and investment products. Strategic partnerships and collaborations with other financial institutions also play a role in enhancing the company's revenue streams by expanding its market reach and product offerings.

Wuestenrot & Wuerttembergische Financial Statement Overview

Summary
Wuestenrot & Wuerttembergische demonstrates moderate financial health with stable revenues and a consistent gross profit margin but faces challenges in maintaining net profitability and efficient operations as seen in declining net profit and EBIT margins. The balance sheet is relatively strong with manageable leverage, though declining ROE is a concern. Cash flow improvements in 2024 suggest recovery, but past volatility needs close monitoring.
Income Statement
68
Positive
Wuestenrot & Wuerttembergische's income statement shows moderate stability with declining revenue over the last two years, although the gross profit margin remains consistent at 100% due to revenue equalling gross profit. The net profit margin decreased significantly from 2.13% in 2023 to 0.55% in 2024. EBIT and EBITDA margins are low, which might indicate efficiency issues in core operations.
Balance Sheet
75
Positive
The balance sheet reflects a strong equity position with a debt-to-equity ratio of 1.04 in 2024, showing moderate leverage. Return on equity (ROE) has decreased from 2.82% in 2023 to 0.69% in 2024, indicating reduced profitability relative to shareholders' equity. The equity ratio of 6.78% in 2024 suggests a relatively low portion of equity financing, consistent with industry norms.
Cash Flow
60
Neutral
Cash flow analysis reveals volatility with an improvement in free cash flow from -178.05 million in 2023 to 265 million in 2024. The operating cash flow to net income ratio increased to 9.79 in 2024, suggesting effective cash generation relative to net income, but past fluctuations pose a risk. The free cash flow to net income ratio was 7.79 in 2024, indicating robust cash conversion.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue6.39B6.15B6.50B5.36B7.72B6.76B
Gross Profit5.94B6.15B5.30B5.36B7.72B6.76B
EBITDA221.29M0.00340.84M403.41M216.19M224.02M
Net Income42.44M34.00M138.66M235.42M350.52M209.91M
Balance Sheet
Total Assets72.70B72.27B68.68B65.50B75.21B76.49B
Cash, Cash Equivalents and Short-Term Investments24.86B24.79B23.87B22.64B33.89B38.23B
Total Debt4.97B5.09B5.75B5.28B4.72B4.03B
Total Liabilities67.71B67.34B63.72B61.79B70.34B71.40B
Stockholders Equity4.95B4.90B4.93B3.71B4.84B5.04B
Cash Flow
Free Cash Flow0.00265.00M-178.05M-2.36B-912.94M275.13M
Operating Cash Flow0.00333.00M-108.12M-2.23B-795.99M434.95M
Investing Cash Flow0.00-66.00M53.71M2.55B350.93M-266.63M
Financing Cash Flow0.00-333.00M-98.22M-102.52M197.37M-20.96M

Wuestenrot & Wuerttembergische Technical Analysis

Technical Analysis Sentiment
Positive
Last Price13.66
Price Trends
50DMA
13.84
Negative
100DMA
13.15
Positive
200DMA
12.32
Positive
Market Momentum
MACD
-0.02
Negative
RSI
52.10
Neutral
STOCH
76.37
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:WUW, the sentiment is Positive. The current price of 13.66 is above the 20-day moving average (MA) of 13.65, below the 50-day MA of 13.84, and above the 200-day MA of 12.32, indicating a neutral trend. The MACD of -0.02 indicates Negative momentum. The RSI at 52.10 is Neutral, neither overbought nor oversold. The STOCH value of 76.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:WUW.

Wuestenrot & Wuerttembergische Peers Comparison

Overall Rating
UnderperformOutperform
Sector (67)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
DEDBK
74
Outperform
$47.94B10.816.68%2.38%3.36%3.08%
71
Outperform
€32.15B14.2819.63%3.38%9.68%18.57%
70
Neutral
€71.20B12.7418.25%3.15%6.63%26.20%
67
Neutral
€10.34B14.386.96%3.50%13.89%1.77%
DERHK
66
Neutral
€816.65M20.583.09%0.70%12.23%-8.23%
DEWUW
64
Neutral
€1.30B38.350.69%4.67%4.19%-75.44%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DE:WUW
Wuestenrot & Wuerttembergische
13.76
1.03
8.05%
DE:HNR1
Hannover Rueck
266.20
39.51
17.43%
DE:DBK
Deutsche Bank AG
24.87
9.42
61.04%
DE:RHK
RHON-KLINIKUM AG
12.20
0.20
1.66%
DE:MUV2
Munich Reinsurance
555.80
120.57
27.70%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 20, 2025